equity

Search documents
NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform
Globenewswire· 2025-07-08 13:00
Core Insights - NeOnc Technologies Holdings, Inc. has signed a non-binding term sheet with Quazar Investment to establish a new investment and clinical platform in the MENA region [1][2] - The partnership aims to leverage the UAE's clinical trial infrastructure to advance NeOnc's late-stage drug candidates [3][7] Investment and Structure - The term sheet outlines the formation of NuroMENA Holdings Ltd, which will oversee the establishment of NuroCure, an Abu Dhabi-based subsidiary responsible for clinical trials [2][5] - A proposed equity investment of $50 million is contingent upon NeOnc meeting specific conditions within 120 days [4][8] Clinical Development - NuroCure will initiate clinical trials for NEO100 and NEO212, targeting aggressive brain cancers such as Diffuse Intrinsic Pontine Glioma and glioblastoma multiforme [7][9] - The partnership is positioned to enhance NeOnc's clinical programs through collaboration with Cleveland Clinic Abu Dhabi [3][10] Financial Strategy - Quazar will lead a capital formation round of up to $50 million, with 70% allocated for acquiring NeOnc common stock and 30% for clinical trial and infrastructure development [8][10] - The investment strategy includes executing a Sub-License Agreement for NEO100 and NEO212, facilitating clinical efforts in the region [5][11] Company Background - NeOnc Technologies is focused on developing therapeutics for central nervous system cancers, with a robust patent portfolio extending to 2038 [11] - The company's drug candidates, NEO100 and NEO212, are currently in Phase II clinical trials under FDA Fast-Track status [11]
Young women are working at near-record rates
MSNBC· 2025-07-08 12:13
>> NEWLY, NEWLY RELEASED DATA SHOWS THAT YOUNG WOMEN ARE WORKING AT NEARLY RECORD RATES. A STUDY FROM THE HAMILTON PROJECT LOOKED AT WORKFORCE PARTICIPATION OF SO-CALLED PRIME AGE MEN AND WOMEN. AND THAT RESEARCH FOUND YOUNG WOMEN NOW ARE ARE MORE LIKELY TO WORK THAN THE SAME AGE GROUP YEARS AGO.NEARLY 78% OF WOMEN IN THEIR 20S AND 30S ARE WORKING. INTERESTINGLY, THE OPPOSITE IS TRUE FOR MEN. THE STUDY FOUND THAT A SMALL BUT GROWING SHARE OF PRIME AGE MEN ARE ACTUALLY TAKING ON MORE OF THE CAREGIVING WORK A ...
X @s4mmy
s4mmy· 2025-07-08 12:05
RT s4mmy (@S4mmyEth)In a sea of red there are two standout tokens this week.The common theme is that they are pushing the boundaries of what's possible within their respective market segments.i) @RektguyAI - The Rekt Litepaper has been published.If there is anything you take away from this, it's the points made around "Liquid Brand Equity" (LBE).I spent more than a decade auditing, performing DD and advising Private and Public companies; "LBE" is an extremely novel concept, and I could see it being adopted ...
Nebius Group: Expect Another Move-Up On Q2 Earnings
Seeking Alpha· 2025-07-08 12:04
With just one subscription to Beyond the Wall Investing , you can save thousands of dollars a year on equity research reports from banks. You'll keep your finger on the pulse and have access to the latest and highest-quality analysis of this type of information.If you read my Seeking Alpha article for some time, you probably know that I was very bullish on Nebius Group N.V.'s (NASDAQ: NBIS ) stock price prospects since January 2025 , and my bullishness paid off as the stockHe leads the investing group Beyon ...
X @s4mmy
s4mmy· 2025-07-08 10:44
RT s4mmy (@S4mmyEth)In a sea of red there are two standout tokens this week.The common theme is that they are pushing the boundaries of what's possible within their respective market segments.i) @RektguyAI - The Rekt Litepaper has been published.If there is anything you take away from this, it's the points made around "Liquid Brand Equity" (LBE).I spent more than a decade auditing, performing DD and advising Private and Public companies; "LBE" is an extremely novel concept, and I could see it being adopted ...
X @s4mmy
s4mmy· 2025-07-08 09:13
In a sea of red there are two standout tokens this week.The common theme is that they are pushing the boundaries of what's possible within their respective market segments.i) @RektguyAI - The Rekt Litepaper has been published.If there is anything you take away from this, it's the points made around "Liquid Brand Equity" (LBE).I spent more than a decade auditing, performing DD and advising Private and Public companies; "LBE" is an extremely novel concept, and I could see it being adopted in the future, provi ...
X @Ansem
Ansem 🧸💸· 2025-07-08 01:48
RT goodalexander (@goodalexander)I don’t buy the “crypto equity story”. The purpose of decentralized bearer assets is to get your money out of the system.Equities are in the system. ETFs are system accelerants. Blackrock is the system adminWe are all here because the system is broken. Not to double down ...
Manulife Financial Stock Near 52-Week High: What Should Investors Do?
ZACKS· 2025-07-07 15:36
Key Takeaways MFC shares closed at $31.88, up 18.1% in the past year and near their 52-week high of $33.07. MFC is focused on high-growth, capital-light, higher-return businesses to accelerate earnings momentum. Analyst estimates for 2025 earnings rose 2.8% in 60 days, with projected growth of 4.2% year over year.Manulife Financial Corporation (MFC) closed at $31.88 on Thursday, near its 52-week high of $33.07. This proximity underscores investor confidence. It has the ingredients for further price apprec ...
MiddleGround Capital Signs Definitive Agreement to Sell Arrow Tru-Line to the Chamberlain Group, a Blackstone Portfolio Company
GlobeNewswire News Room· 2025-07-07 15:01
LEXINGTON, Ky., July 07, 2025 (GLOBE NEWSWIRE) -- MiddleGround Capital (“MiddleGround”), an operationally focused private equity firm that makes control investments in North American and European headquartered middle-market B2B industrial and specialty distribution companies, today announced that it has entered a definitive agreement to sell its portfolio company Arrow Tru-Line (“ATL”), an independent manufacturer and supplier of structurally critical overhead garage door hardware components, to the Chamber ...
OneMain Holdings Hits 52-Week High: Should You Buy the Stock Now?
ZACKS· 2025-07-07 13:45
Core Insights - OneMain Holdings, Inc. (OMF) shares reached a 52-week high of $60.08, with a 47.8% increase over the past three months, outperforming the industry and S&P 500 Index [1][8] - The company's revenue has shown a five-year compound annual growth rate (CAGR) of 3.6%, driven by growth in net interest income [4] - OneMain Holdings has a trailing 12-month return on equity (ROE) of 19.30%, significantly higher than the industry average of 10.11% [11][12] Revenue Growth - The company aims to enhance margins by reducing Back Book over time and has strengthened its auto finance capabilities through the acquisition of Foursight [5] - OneMain Holdings is expected to continue top-line growth due to its diversified product base and efforts to expand credit card and auto finance businesses [4][5] Financial Position - As of March 31, 2025, OneMain Holdings had total debt of $22.2 billion and cash and cash equivalents of $1.4 billion, indicating a decent balance sheet position [9] - The company has a share repurchase program worth $1 billion, with $609.8 million remaining as of March 31, 2025 [11] Expense Trends - Total other expenses have seen a CAGR of 3% over the last five years, primarily due to rising salaries and benefits [15] - Elevated expenses are expected to persist as the company invests in new products and capabilities [16] Asset Quality Concerns - Provision for finance receivable losses has a CAGR of 9.1% over the past five years, indicating underwriting concerns [19] - The allowance ratio has consistently increased, suggesting challenges in asset quality that may hinder growth [21] Valuation Metrics - OMF stock has a P/E (F1) ratio of 9.68, below the industry average of 11.72, indicating it may be undervalued [22] - Despite the attractive valuation, analysts have revised earnings estimates lower for 2025 and 2026, reflecting concerns over growth potential [25]